Don't Just Read the News, Understand It.
Published loading...Updated

Trump to continue Biden's court defense of abortion drug mifepristone

  • The Trump administration remains committed to upholding FDA regulations that facilitate the availability of the abortion medication mifepristone in ongoing litigation before Judge Matthew Kacsmaryk in Texas.
  • The case began under the Biden administration after three Republican-led states sued to restrict telehealth prescriptions and in-person visit rules for mifepristone.
  • The states argue access to mifepristone undermines their abortion laws in Idaho, Missouri, and Kansas, which have varied abortion restrictions and recent reproductive rights developments.
  • The Supreme Court rejected an earlier challenge, ruling the plaintiffs lacked standing, and the government now urges dismissal on procedural grounds without addressing drug access merits.
  • This defense suggests the administration will maintain current drug access policies despite opposition, indicating ongoing legal and political conflict over abortion medication post-Roe v. Wade.
Insights by Ground AI
Does this summary seem wrong?

50 Articles

All
Left
20
Center
14
Right
4
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 53% of the sources lean Left
53% Left
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

U.S. News broke the news in New York, United States on Monday, May 5, 2025.
Sources are mostly out of (0)

You have read out of your 5 free daily articles.

Join us as a member to unlock exclusive access to diverse content.